A new study from researchers at Environmental Influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health shows how a stress scale developed to identify who was most at-risk of needing mental health support during the pandemic has the potential to evaluate traumatic stress reactions to ongoing large-scale threats.
...Previous studies have revealed disparities in COVID-19-related deaths among population demographics, including age, race and pre-existing medical conditions, but a new study by the University of Minnesota School of Public Health (SPH) has determined another factor – a person’s profession.
A new investigation led by researchers from the University College London and Dartmouth College suggests 14% of Americans had long COVID by the end of 2022. The details of the investigation are published in PLOS One.
Moreover, Americans who report having experienced long COVID said they also experienced more anxiety, low mood, and difficulty with memory. ...
The chief scientist from the World Health Organization is warning that Earth’s rising temperature will make dengue fever a massive threat within this decade.
A study based on 211 pregnant women given the antiviral drug nirmatrelvir and ritonavir (Paxlovid) during pregnancy for acute COVID-19 infections shows no increased risk of adverse events in the women or their babies and a reduced risk of complications called the maternal morbidity and mortality index (MMMI).
The findings, published today in Nature Medicine, suggest the drug is safe to use in pregnancy and is effective in reducing MMMI risk but not COVID-related hospitalizations.
